Abstract
Its spreading speed together with the risk of fatality might be the main characteristic that separates COVID-19 from other infectious diseases in our recent history. In this scenario, mathematical modeling for predicting the spread of the disease could have great value in containing the disease. Several very recent papers have contributed to this purpose. In this study we propose a birth-and-death model for predicting the number of COVID-19 active cases. It relation to the Susceptible-Infected-Recovered (SIR) model has been discussed. An explicit expression for the expected number of active cases helps us to identify a stationary point on the infection curve, where the infection ceases increasing. Parameters of the model are estimated by fitting the expressions for active and total reported cases simultaneously. We analyzed the movement of the stationary point and the basic reproduction number during the infection period up to the 20th of April 2020. These provide information about the disease progression path and therefore could be really useful in designing containment strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for the current study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Government Engineering College, Thrissur, Kerala, India
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The COVID-19 cases data can be found in the website https://www.worldometers.info.
